These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18196516)

  • 1. Ligand binding of leukocyte integrin very late antigen-4 involves exposure of sulfhydryl groups and is subject to redox modulation.
    Liu SY; Tsai MY; Chuang KP; Huang YF; Shieh CC
    Eur J Immunol; 2008 Feb; 38(2):410-23. PubMed ID: 18196516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow.
    Chen C; Mobley JL; Dwir O; Shimron F; Grabovsky V; Lobb RR; Shimizu Y; Alon R
    J Immunol; 1999 Jan; 162(2):1084-95. PubMed ID: 9916737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide activates very late antigen-4 on an eosinophil cell line and increases cellular binding to vascular cell adhesion molecule-1.
    Chuang KP; Tsai WS; Wang YJ; Shieh CC
    Eur J Immunol; 2003 Mar; 33(3):645-55. PubMed ID: 12616485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
    Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
    Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
    Klemke M; Weschenfelder T; Konstandin MH; Samstag Y
    J Cell Physiol; 2007 Aug; 212(2):368-74. PubMed ID: 17352405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation.
    Hafezi-Moghadam A; Noda K; Almulki L; Iliaki EF; Poulaki V; Thomas KL; Nakazawa T; Hisatomi T; Miller JW; Gragoudas ES
    FASEB J; 2007 Feb; 21(2):464-74. PubMed ID: 17202250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependence.
    Egger LA; Cao J; McCallum C; Kidambi U; Van Riper G; McCauley E; Mumford RA; Lanza TJ; Lin LS; de Laszlo SE; Young DN; Yang G; Dean DC; Raab CE; Wallace MA; Jones AN; Hagmann WK; Schmidt JA; Pepinsky RB; Scott DM; Lee WC; Cornebise MA; Detmers PA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):903-13. PubMed ID: 12766251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes.
    Laudanna C; Alon R
    Thromb Haemost; 2006 Jan; 95(1):5-11. PubMed ID: 16543955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha4beta1 integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following carotid injury in apolipoprotein E (-/-) mice.
    Barringhaus KG; Phillips JW; Thatte JS; Sanders JM; Czarnik AC; Bennett DK; Ley KF; Sarembock IJ
    J Vasc Res; 2004; 41(3):252-60. PubMed ID: 15153775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma cell adhesion can be blocked by heparin in vitro: suggestion of VLA-4 as a novel target for antimetastatic approaches.
    Fritzsche J; Simonis D; Bendas G
    Thromb Haemost; 2008 Dec; 100(6):1166-75. PubMed ID: 19132244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
    Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin modulation and signaling in leukocyte adhesion and migration.
    Rose DM; Alon R; Ginsberg MH
    Immunol Rev; 2007 Aug; 218():126-34. PubMed ID: 17624949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration.
    Kelly KA; Allport JR; Yu AM; Sinh S; Sage EH; Gerszten RE; Weissleder R
    J Leukoc Biol; 2007 Mar; 81(3):748-56. PubMed ID: 17178915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to vascular cell adhesion molecule 1 (VCAM-1) under shear flow.
    Feigelson SW; Grabovsky V; Shamri R; Levy S; Alon R
    J Biol Chem; 2003 Dec; 278(51):51203-12. PubMed ID: 14532283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.
    Rice GP; Hartung HP; Calabresi PA
    Neurology; 2005 Apr; 64(8):1336-42. PubMed ID: 15851719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the alpha4 integrin-paxillin interaction in regulating leukocyte trafficking.
    Rose DM
    Exp Mol Med; 2006 Jun; 38(3):191-5. PubMed ID: 16819276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon monoxide down-regulates α4β1 integrin-specific ligand binding and cell adhesion: a possible mechanism for cell mobilization.
    Chigaev A; Smagley Y; Sklar LA
    BMC Immunol; 2014 Oct; 15():52. PubMed ID: 25367365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory control of human cytosolic branched-chain aminotransferase by oxidation and S-glutathionylation and its interactions with redox sensitive neuronal proteins.
    Conway ME; Coles SJ; Islam MM; Hutson SM
    Biochemistry; 2008 May; 47(19):5465-79. PubMed ID: 18419134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell activation by membrane-bound antigens is facilitated by the interaction of VLA-4 with VCAM-1.
    Carrasco YR; Batista FD
    EMBO J; 2006 Feb; 25(4):889-99. PubMed ID: 16456548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.